DOCS Stock Recent News
DOCS LATEST HEADLINES
Doximity (DOCS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
AI stock predictions are all the rage, and for good reason. I asked Google's Bard and ChatGPT to give me some predictions regarding which stocks will soar soon.
Pfizer has important, ongoing projects that should start to pay off down the road. Doximity's strong margins, moat, and growth opportunities could mean a bright future.
Digital health and telemedicine are booming sectors offering attractive opportunities to investors looking to capitalize on the growing demand for remote healthcare. A couple of years ago, the Covid-19 pandemic accelerated the adoption of digital health solutions such as online consultations, remote monitoring, and digital prescriptions.
Doximity (DOCS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Investors looking for stocks in the Medical Services sector might want to consider either Icon PLC (ICLR) or Doximity (DOCS). But which of these two stocks offers value investors a better bang for their buck right now?
The online platform for medical professionals also reported fiscal second-quarter adjusted earnings that beat analysts' estimates.
Doximity, Inc. (NYSE:DOCS ) Q2 2024 Earnings Conference Call November 9, 2023 5:00 PM ET Company Participants Perry Gold - VP of IR Jeffrey Tangney - Co-Founder & CEO Anna Bryson - CFO Nate Gross - Co-Founder & CSO Conference Call Participants Brian Peterson - Raymond James Richard Close - Canaccord Genuity Ryan Daniels - William Blair Scott Berg - Needham & Company Samir Patel - Evercore ISI Jessica Tassan - Piper Sandler Scott Schoenhaus - KeyBanc Craig Hettenbach - Morgan Stanley Jailendra Singh - Truist Securities Allen Lutz - Bank of America Glen Santangelo - Jefferies David Larsen - BTIG Operator Good afternoon. My name is Krista and I'll be your conference operator today.
Although the revenue and EPS for Doximity (DOCS) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Doximity announced a free new service called DocDefender that can remove a physician's personal phone numbers and addresses from public websites